CRMDCorMedix Inc.

$7.31-34% 1Y

RyuScore

Seven criteria, each scored 0 to 100 on a published scale, weighted into one number.

RyuScore 60 out of 100, Above average

Above average. CorMedix Inc. scores higher than 61% of the 2,291 companies Ryufin scores.

Carried by valuation and return on new capital, held back by return on capital and capital allocation.

Healthcare median 18 · all companies 54

How the score has moved

At each fiscal year end, from the reports and price of the time
8
7
7
7
0
60
20202021202220232024today

The biggest move was up 60 points from 2024 to today, mostly valuation.

Valuation

26% of the score, 30% here after data gaps

100median 50

CorMedix Inc. is valued at 2.4x its operating profit before acquisition amortisation (EBITA), including debt: cheap enough for full points.

60x
50x
35x
25x
18x
12x
8x
2.4x
Full points at 8x or less, none from 60xfull points

Return on capital

18% of the score, 20% here after data gaps

0median 23

Over 7 years the business earned -11% a year after tax on the capital it uses.

2%
8%
15%
25%
-11%
None at 2% or less, full points from 25%full points
Return on capital by year
7 years agolatest 56%

Return on new capital

16% of the score, 18% here after data gaps

100median 33

For every dollar of operating profit earned over 6 years, yearly profit grew by 491 cents. New capital earned 34%, and 1438% of profit went back into the business.

-5%
12%
491%
None at minus 5 cents, full points from 12 centsfull points

Capital allocation

14% of the score, 16% here after data gaps

0median 63

How management spends the money: shares bought back or issued, and whether assets grow faster than the business they serve.

Share countUp 19.5% a year over 5 years: new shares
0
5%
-3%
20%
0 pointsfull points

Cycle position

Taken out: its 12% is shared by the others

n/ano data

Margins have been too thin to measure a cycle against.

Balance sheet

8% of the score, 9% here after data gaps

100median 50

What the debt weighs against the profit that has to carry it.

Interest coverOperating profit covers interest 78x
100
1.5x
12x
78x
0 pointsfull points

Earnings quality

6% of the score, 7% here after data gaps

53median 90

Whether the reported profit arrives as cash, and whether the accounts show the usual signs of stretching.

Cash against profitOperating cash flow was 0.87x profit over 3 years
34
0.7x
1x
1.3x
0.9x
0 pointsfull points
AccrualsCash ran ahead of profit by 2.5% of assets
73
8%
0%
-8%
-2.5%
0 pointsfull points

How the RyuScore works

Each criterion earns 0 to 100 points on the scale drawn under it, and the RyuScore is their average weighted 26, 18, 16, 14, 12, 8 and 6. Scales bend in the company's favour between their ends, so an ordinary figure is never already near zero. For CRMD, cycle position could not be measured from the filings, so it is taken out and the remaining weights scale up.

Built from the company's annual and quarterly filings with the SEC and today's share price. Banks, insurers and property trusts are not scored: their debt is their raw material, so these yardsticks mean something else there. Figures as of 2026-06-30, latest annual report FY2025.